Literature DB >> 312282

Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.

S Castells, C Chakrabarti, B G Winsberg, M Hurwic, J M Perel, W L Nyhan.   

Abstract

In a patient with the Lesch-Nyhan syndrome we found decreased spinal fluid 5-hydroxyindole acetic acid (5-HIAA), the major metabolite of serotonin, and decreased homovanillic acid (HVA), the major metabolite of dopamine, indicating a decrease in monoamine metabolism. Administration of 5-hydroxytryptophan and carbidopa produced an increase in spinal fluid 5-HIAA, indicating that it might be possible to correct the serotonin deficiency in this syndrome, but there were no changes in the marked mental retardation and neurological deficits. Self-mutilation appeared to be suppressed by therapy but the effectiveness of the drugs decreased with time. There were also changes in the spinal fluid concentration of amino acids that might affect brain protein synthesis. These changes were corrected during administration of 5-hydroxytryptophan and carbidopa.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312282     DOI: 10.1007/bf01531296

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  18 in total

1.  Behavior in the Lesch--Nyhan syndrome.

Authors:  W L Nyhan
Journal:  J Autism Child Schizophr       Date:  1976-09

2.  REGULATION OF CEREBRAL METABOLISM OF AMINO ACIDS. IV. INFLUENCE OF AMINO ACID LEVELS ON LEUCINE UPTAKE, UTILIZATION AND INCORPORATION INTO PROTEIN IN VIVO.

Authors:  S ROBERTS; B S MORELOS
Journal:  J Neurochem       Date:  1965-05       Impact factor: 5.372

3.  The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material.

Authors:  P G DAYTON; T F YU; W CHEN; L BERGER; L A WEST; A B GUTMAN
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

4.  Parkinson's disease. Modification by 5-hydroxytryptophan.

Authors:  T N Chase; L K Ng; A M Watanabe
Journal:  Neurology       Date:  1972-05       Impact factor: 9.910

5.  Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.

Authors:  E M Airaksinen; K Kauko
Journal:  Ann Clin Res       Date:  1973-12

6.  Evidence for inhibition by brain serotonin of mouse killing behaviour in rats.

Authors:  G Di Chiara; R Camba; P F Spano
Journal:  Nature       Date:  1971-09-24       Impact factor: 49.962

Review 7.  Drugs and aggressiveness.

Authors:  L Valzelli
Journal:  Adv Pharmacol       Date:  1967

8.  The distribution of 5-hydroxyindoleacetic acid in various animals and its fluorometric analysis in diverse biological material.

Authors:  A H Anton; D F Sayre
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

9.  Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.

Authors:  R Olsson; B E Roos
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

10.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

View more
  6 in total

1.  Intrastriatal injection of hypoxanthine reduces striatal serotonin content and impairs spatial memory performance in rats.

Authors:  Caren Serra Bavaresco; Fabria Chiarani; Eduardo Duringon; Marcelo Machado Ferro; Cláudio Da Cunha; Carlos Alexandre Netto; Angela Terezinha de Souza Wyse
Journal:  Metab Brain Dis       Date:  2007-01-13       Impact factor: 3.584

Review 2.  Lesch-Nyhan Syndrome: Models, Theories, and Therapies.

Authors:  Scott Bell; Ilaria Kolobova; Liam Crapper; Carl Ernst
Journal:  Mol Syndromol       Date:  2016-09-24

3.  Contributions of Lesch-Nyhan syndrome to the understanding of purine metabolism.

Authors:  J E Seegmiller
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Platelet abnormalities in aggressive subjects with mental deficiency.

Authors:  D Marazziti; L Palego; S Silvestri; S Presta; C Balestri; A Batistini; L Conti
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

5.  Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF.

Authors:  R A Harkness; G M McCreanor; R W Watts
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 6.  Dopamine function in Lesch-Nyhan disease.

Authors:  W L Nyhan
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.